the K-power model (K ≥ 1). That approach estimates a BMDL of 58 ppb of Hg in cord blood (corresponding to a BMDL of 12 ppm of Hg in hair) as a reasonable point of departure for deriving the RfD. To calculate the RfD, the BMDL should be divided by uncertainty factors that take into consideration biological variability when estimating dose and MeHg data-base insufficiencies. As stated earlier, given those considerations, an uncertainty factor of at least 10 is supported by the committee.

The committee further concludes that the case of MeHg presents a strong illustration of the need for harmonization of efforts to establish a common scientific basis for exposure guidance and to reduce current differences among agencies, recognizing that risk-management efforts reflect the differing mandates and responsibilities of the agencies.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement